PREVYMIS letermovir 480 mg film-coated tablet blister pack ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

prevymis letermovir 480 mg film-coated tablet blister pack

merck sharp & dohme (australia) pty ltd - letermovir, quantity: 480 mg - tablet, film coated - excipient ingredients: povidone; croscarmellose sodium; magnesium stearate; silicon dioxide; microcrystalline cellulose; carnauba wax; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow; iron oxide red - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

PREVYMIS letermovir 240 mg  film-coated tablet blister pack ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

prevymis letermovir 240 mg film-coated tablet blister pack

merck sharp & dohme (australia) pty ltd - letermovir, quantity: 240 mg - tablet, film coated - excipient ingredients: carnauba wax; croscarmellose sodium; magnesium stearate; silicon dioxide; microcrystalline cellulose; povidone; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

Intron A Redipen न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

intron a redipen

merck sharp & dohme (new zealand) limited - interferon alfa-2b 15 miu/ml - solution for injection - 18 miu - active: interferon alfa-2b 15 miu/ml excipient: dibasic sodium phosphate disodium edetate dihydrate metacresol monobasic sodium phosphate monohydrate polysorbate 80 sodium chloride water for injection - intron a redipen is used in the treatment of: · hairy cell leukaemia in splenectomised or non-splenectomised patients; · chronic myelogenous leukaemia;

Intron A Redipen न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

intron a redipen

merck sharp & dohme (new zealand) limited - interferon alfa-2b 25 miu/ml - solution for injection - 30 miu - active: interferon alfa-2b 25 miu/ml excipient: dibasic sodium phosphate disodium edetate dihydrate metacresol monobasic sodium phosphate monohydrate polysorbate 80 sodium chloride water for injection - intron a redipen is used in the treatment of: · hairy cell leukaemia in splenectomised or non-splenectomised patients; · chronic myelogenous leukaemia;

Intron A Redipen न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

intron a redipen

merck sharp & dohme (new zealand) limited - interferon alfa-2b 50 miu/ml - solution for injection - 60 miu - active: interferon alfa-2b 50 miu/ml excipient: dibasic sodium phosphate disodium edetate dihydrate metacresol monobasic sodium phosphate monohydrate polysorbate 80 sodium chloride water for injection - intron a redipen is used in the treatment of: · hairy cell leukaemia in splenectomised or non-splenectomised patients; · chronic myelogenous leukaemia;